INNOVIVA INC (INVA) Fundamental Analysis & Valuation

NASDAQ:INVA • US45781M1018

22.125 USD
-0.61 (-2.66%)
Last: Mar 5, 2026, 12:14 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This INVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

INVA gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. Both the health and profitability get an excellent rating, making INVA a very profitable company, without any liquidiy or solvency issues. INVA scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make INVA a good candidate for value and quality investing.


Dividend Valuation Growth Profitability Health

7

1. INVA Profitability Analysis

1.1 Basic Checks

  • In the past year INVA was profitable.
  • INVA had a positive operating cash flow in the past year.
  • INVA had positive earnings in each of the past 5 years.
  • Each year in the past 5 years INVA had a positive operating cash flow.
INVA Yearly Net Income VS EBIT VS OCF VS FCFINVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • INVA has a Return On Assets of 16.58%. This is amongst the best in the industry. INVA outperforms 95.85% of its industry peers.
  • INVA has a Return On Equity of 23.12%. This is amongst the best in the industry. INVA outperforms 92.23% of its industry peers.
  • INVA's Return On Invested Capital of 7.51% is amongst the best of the industry. INVA outperforms 86.53% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for INVA is below the industry average of 12.91%.
Industry RankSector Rank
ROA 16.58%
ROE 23.12%
ROIC 7.51%
ROA(3y)10.94%
ROA(5y)15.78%
ROE(3y)17.71%
ROE(5y)31.01%
ROIC(3y)8.6%
ROIC(5y)13.83%
INVA Yearly ROA, ROE, ROICINVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

1.3 Margins

  • INVA's Profit Margin of 65.92% is amongst the best of the industry. INVA outperforms 97.93% of its industry peers.
  • In the last couple of years the Profit Margin of INVA has remained more or less at the same level.
  • INVA has a Operating Margin of 39.81%. This is amongst the best in the industry. INVA outperforms 97.41% of its industry peers.
  • INVA's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 74.80%, INVA belongs to the top of the industry, outperforming 81.87% of the companies in the same industry.
  • INVA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 39.81%
PM (TTM) 65.92%
GM 74.8%
OM growth 3Y-13.95%
OM growth 5Y-16.03%
PM growth 3Y0.7%
PM growth 5Y-0.21%
GM growth 3Y-7.93%
GM growth 5YN/A
INVA Yearly Profit, Operating, Gross MarginsINVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. INVA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), INVA is creating some value.
  • INVA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for INVA has been reduced compared to 5 years ago.
  • Compared to 1 year ago, INVA has an improved debt to assets ratio.
INVA Yearly Shares OutstandingINVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
INVA Yearly Total Debt VS Total AssetsINVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.50 indicates that INVA is not in any danger for bankruptcy at the moment.
  • INVA has a Altman-Z score of 3.50. This is in the better half of the industry: INVA outperforms 70.98% of its industry peers.
  • INVA has a debt to FCF ratio of 1.38. This is a very positive value and a sign of high solvency as it would only need 1.38 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.38, INVA belongs to the top of the industry, outperforming 95.85% of the companies in the same industry.
  • INVA has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
  • INVA has a Debt to Equity ratio (0.22) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.38
Altman-Z 3.5
ROIC/WACC0.89
WACC8.41%
INVA Yearly LT Debt VS Equity VS FCFINVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 14.64 indicates that INVA has no problem at all paying its short term obligations.
  • The Current ratio of INVA (14.64) is better than 84.46% of its industry peers.
  • A Quick Ratio of 13.85 indicates that INVA has no problem at all paying its short term obligations.
  • INVA has a Quick ratio of 13.85. This is amongst the best in the industry. INVA outperforms 84.46% of its industry peers.
Industry RankSector Rank
Current Ratio 14.64
Quick Ratio 13.85
INVA Yearly Current Assets VS Current LiabilitesINVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. INVA Growth Analysis

3.1 Past

  • INVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1505.26%, which is quite impressive.
  • INVA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.59% yearly.
  • INVA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.67%.
  • The Revenue has been growing slightly by 4.08% on average over the past years.
EPS 1Y (TTM)1505.26%
EPS 3Y11.17%
EPS 5Y8.59%
EPS Q2Q%646.15%
Revenue 1Y (TTM)14.67%
Revenue growth 3Y7.48%
Revenue growth 5Y4.08%
Sales Q2Q%24.84%

3.2 Future

  • INVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.11% yearly.
  • INVA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.69% yearly.
EPS Next Y-34.18%
EPS Next 2Y-15.45%
EPS Next 3Y-12.55%
EPS Next 5Y21.11%
Revenue Next Year9.86%
Revenue Next 2Y10.92%
Revenue Next 3Y8.64%
Revenue Next 5Y5.69%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVA Yearly Revenue VS EstimatesINVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M 500M
INVA Yearly EPS VS EstimatesINVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

8

4. INVA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.25, which indicates a rather cheap valuation of INVA.
  • Based on the Price/Earnings ratio, INVA is valued cheaper than 93.78% of the companies in the same industry.
  • INVA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.03.
  • A Price/Forward Earnings ratio of 11.02 indicates a reasonable valuation of INVA.
  • INVA's Price/Forward Earnings ratio is rather cheap when compared to the industry. INVA is cheaper than 87.05% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 25.11. INVA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.25
Fwd PE 11.02
INVA Price Earnings VS Forward Price EarningsINVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, INVA is valued cheaper than 93.78% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of INVA indicates a rather cheap valuation: INVA is cheaper than 92.75% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.79
EV/EBITDA 6.66
INVA Per share dataINVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The decent profitability rating of INVA may justify a higher PE ratio.
  • INVA's earnings are expected to decrease with -12.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.84
EPS Next 2Y-15.45%
EPS Next 3Y-12.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INVA Dividend Analysis

5.1 Amount

  • INVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INVA Fundamentals: All Metrics, Ratios and Statistics

INNOVIVA INC

NASDAQ:INVA (3/5/2026, 12:14:53 PM)

22.125

-0.61 (-2.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners106.59%
Inst Owner Change-2.52%
Ins Owners1.07%
Ins Owner Change3.42%
Market Cap1.64B
Revenue(TTM)411.33M
Net Income(TTM)271.17M
Analysts81.82
Price Target33.66 (52.14%)
Short Float %9.08%
Short Ratio8.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)182.63%
Min EPS beat(2)119.45%
Max EPS beat(2)245.81%
EPS beat(4)3
Avg EPS beat(4)16.52%
Min EPS beat(4)-350.17%
Max EPS beat(4)245.81%
EPS beat(8)4
Avg EPS beat(8)-27.73%
EPS beat(12)7
Avg EPS beat(12)20.38%
EPS beat(16)8
Avg EPS beat(16)-23.72%
Revenue beat(2)2
Avg Revenue beat(2)12.62%
Min Revenue beat(2)9.49%
Max Revenue beat(2)15.75%
Revenue beat(4)4
Avg Revenue beat(4)9.29%
Min Revenue beat(4)5.11%
Max Revenue beat(4)15.75%
Revenue beat(8)8
Avg Revenue beat(8)12.23%
Revenue beat(12)11
Avg Revenue beat(12)11.26%
Revenue beat(16)12
Avg Revenue beat(16)1.54%
PT rev (1m)1.54%
PT rev (3m)-10.33%
EPS NQ rev (1m)-8.33%
EPS NQ rev (3m)-38.2%
EPS NY rev (1m)0%
EPS NY rev (3m)80%
Revenue NQ rev (1m)1.08%
Revenue NQ rev (3m)1.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.87%
Valuation
Industry RankSector Rank
PE 7.25
Fwd PE 11.02
P/S 3.98
P/FCF 8.79
P/OCF 8.32
P/B 1.4
P/tB 1.79
EV/EBITDA 6.66
EPS(TTM)3.05
EY13.79%
EPS(NY)2.01
Fwd EY9.07%
FCF(TTM)2.52
FCFY11.38%
OCF(TTM)2.66
OCFY12.02%
SpS5.55
BVpS15.83
TBVpS12.38
PEG (NY)N/A
PEG (5Y)0.84
Graham Number32.96
Profitability
Industry RankSector Rank
ROA 16.58%
ROE 23.12%
ROCE 10.33%
ROIC 7.51%
ROICexc 11.69%
ROICexgc 15.62%
OM 39.81%
PM (TTM) 65.92%
GM 74.8%
FCFM 45.32%
ROA(3y)10.94%
ROA(5y)15.78%
ROE(3y)17.71%
ROE(5y)31.01%
ROIC(3y)8.6%
ROIC(5y)13.83%
ROICexc(3y)12.83%
ROICexc(5y)19.03%
ROICexgc(3y)20.63%
ROICexgc(5y)28.4%
ROCE(3y)11.81%
ROCE(5y)19.01%
ROICexgc growth 3Y-23.7%
ROICexgc growth 5Y-16.1%
ROICexc growth 3Y-14.48%
ROICexc growth 5Y-17.86%
OM growth 3Y-13.95%
OM growth 5Y-16.03%
PM growth 3Y0.7%
PM growth 5Y-0.21%
GM growth 3Y-7.93%
GM growth 5YN/A
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.38
Debt/EBITDA 1.26
Cap/Depr 26.1%
Cap/Sales 2.55%
Interest Coverage 15.82
Cash Conversion 96.55%
Profit Quality 68.75%
Current Ratio 14.64
Quick Ratio 13.85
Altman-Z 3.5
F-Score5
WACC8.41%
ROIC/WACC0.89
Cap/Depr(3y)12.65%
Cap/Depr(5y)7.7%
Cap/Sales(3y)1.29%
Cap/Sales(5y)0.78%
Profit Quality(3y)311.8%
Profit Quality(5y)233.29%
High Growth Momentum
Growth
EPS 1Y (TTM)1505.26%
EPS 3Y11.17%
EPS 5Y8.59%
EPS Q2Q%646.15%
EPS Next Y-34.18%
EPS Next 2Y-15.45%
EPS Next 3Y-12.55%
EPS Next 5Y21.11%
Revenue 1Y (TTM)14.67%
Revenue growth 3Y7.48%
Revenue growth 5Y4.08%
Sales Q2Q%24.84%
Revenue Next Year9.86%
Revenue Next 2Y10.92%
Revenue Next 3Y8.64%
Revenue Next 5Y5.69%
EBIT growth 1Y-1.87%
EBIT growth 3Y-7.52%
EBIT growth 5Y-12.6%
EBIT Next Year60.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.09%
FCF growth 3Y-2.57%
FCF growth 5Y-9.85%
OCF growth 1Y4.37%
OCF growth 3Y-0.79%
OCF growth 5Y-8.86%

INNOVIVA INC / INVA FAQ

Can you provide the ChartMill fundamental rating for INNOVIVA INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVA.


Can you provide the valuation status for INNOVIVA INC?

ChartMill assigns a valuation rating of 8 / 10 to INNOVIVA INC (INVA). This can be considered as Undervalued.


What is the profitability of INVA stock?

INNOVIVA INC (INVA) has a profitability rating of 7 / 10.


What is the earnings growth outlook for INNOVIVA INC?

The Earnings per Share (EPS) of INNOVIVA INC (INVA) is expected to decline by -34.18% in the next year.


How sustainable is the dividend of INNOVIVA INC (INVA) stock?

The dividend rating of INNOVIVA INC (INVA) is 0 / 10 and the dividend payout ratio is 0%.